CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ 14,191	$ (319,820)
(Income) / Loss from discontinued operations	(108,807)	0
Adjustments to reconcile net income (loss) to net cash used in operating activities
Gain on disposal of subsidiary	(109,600)	0
Amortization of debt issuance cost	67,571	0
Share based compensation	0	750
(Increase) decrease in current assets:
Accounts receivable	(95,417)	0
Inventory	(85,849)	0
Other current assets	(182,931)	0
Increase (decrease) in current liabilities:
Accounts payable & accrued expenses	16,275	10,948
Net cash used in operating activities - continuing operations	(484,567)	(308,122)
Net provided by operating activities - discontinued operations	0	107,191
Net cash used in operating activities	(484,567)	(200,931)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payment of cash to subsidiary disposed as part of sale agreement	(353,100)	0
Net cash used in investing activities - continuing operations	(353,100)	0
Net cash used in investing activities - discontinued operations	0	(10,783)
Net cash used in investing activities	(353,100)	(10,783)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from related party notes payable	0	10,000
Repayments of related party debts	(29,500)	0
Proceeds from notes payable & debentures	43,500	118,000
Repayments of notes payable & debentures	(222,000)	0
Proceeds from sale of common shares	1,160,000	0
Proceeds from sale of preferred shares	1,840,000	0
Net cash provided by financing activities - continuing operations	2,792,000	128,000
Net cash provided by financing activities - discontinued operations	0	60,000
Net cash provided by financing activities	2,792,000	188,000
NET DECREASE IN CASH & CASH EQUIVALENTS	1,954,332	(23,714)
CASH & CASH EQUIVALENTS, BEGINNING BALANCE	15,730	39,444
CASH & CASH EQUIVALENTS, ENDING BALANCE	1,970,062	15,730
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Beneficial conversion feature for issuance of Series B Preferred Stock	1,470,053	0
Cancellation of common stock in connection with disposal of subsidiary	(502,616)	0
Issuance of common stock in settlement of convertible debentures & Notes & Accrued Interest	158,061	0
Series B preferred shares converted to common shares	0
Common Stock issued as loan fee	$ 0	$ 750